IMMP
IMMUTEP SP ADR (IMMP)
NASDAQ
$3.65+$0.08 (+2.39%)
Price as of Nov 12, 2026 5:05 AM EST
  • $26.2M
    Market Cap
  • -90.06%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2026
06/30/2025
06/30/2024
06/30/2023
Income Statement
Total Operating Revenue
24.2M
+133.94%
10.3M
+31.80%
7.8M
+50.74%
5.2M
-23.05%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
24.2M
+133.94%
10.3M
+31.80%
7.8M
+50.74%
5.2M
-23.05%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-76.7M
+53.99%
-49.8M
+58.17%
-31.5M
+9.30%
-28.8M
+13.64%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
9.6M
+10.81%
8.6M
-2.35%
8.9M
+1.99%
8.7M
+20.38%
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-79.3M
+29.09%
-61.4M
+43.82%
-42.7M
+7.07%
-39.9M
+23.86%
Income Taxes
0
N/A
0
N/A
0
N/A
0
-100.00%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-79.3M
+29.09%
-61.4M
+43.82%
-42.7M
+7.07%
-39.9M
+23.86%
Net Income from Continuing Operations Applicable to Common
-79.3M
+29.09%
-61.4M
+43.82%
-42.7M
+7.07%
-39.9M
+23.86%
Basic EPS and Net Income
-0.05
+27.73%
-0.04
+18.54%
-0.04
-20.36%
-0.04
+17.94%
Diluted EPS and Net Income
-0.05
+27.73%
-0.04
+18.54%
-0.04
-20.36%
-0.04
+17.94%
Basic Weighted Average Shares
1.5B
+1.08%
1.5B
+21.21%
1.2B
+34.59%
892.4M
+5.12%
Diluted Weighted Average Shares
1.5B
+1.08%
1.5B
+21.21%
1.2B
+34.59%
892.4M
+5.12%
Balance Sheet
Cash and Cash Equivalents
63.7M
-5.54%
67.4M
-58.34%
161.8M
+31.09%
123.4M
+54.28%
Short-Term Investments
0
-100.00%
12.5M
-37.77%
20.1M
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
63.7M
-20.32%
79.9M
-56.06%
181.9M
+47.37%
123.4M
+54.28%
Total Current Assets
80.6M
-45.92%
149.1M
-22.08%
191.4M
+41.78%
135.0M
+48.62%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
110,608
+74.30%
63,458
+0.50%
63,145
-24.05%
83,144
+119.19%
Total Long-Term Assets
2.6M
-66.51%
7.9M
-22.90%
10.2M
-18.06%
12.5M
+9.91%
Total Assets
83.3M
-46.96%
157.0M
-22.12%
201.6M
+36.71%
147.4M
+44.32%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
14.2M
+10.99%
12.8M
+21.67%
10.5M
+7.31%
9.8M
+52.34%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
7.6M
+1,185.30%
589,227
-62.50%
1.6M
+30.12%
1.2M
-28.03%
Total Liabilities
21.7M
+62.83%
13.3M
+10.70%
12.1M
+9.82%
11.0M
+35.68%
Retained Earnings
-520.8M
+17.28%
-444.1M
+16.06%
-382.6M
+12.57%
-339.9M
+12.43%
Total Stockholders Equity
61.5M
-57.16%
143.6M
-24.21%
189.5M
+38.87%
136.5M
+45.06%
Total Shares Outstanding
1.5B
+0.91%
1.5B
+0.54%
1.5B
+22.35%
1.2B
+37.06%
Cash Flow
Cash from Operating Activities
-55.5M
-10.61%
-62.0M
+78.20%
-34.8M
-1.51%
-35.4M
+16.96%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
56.5M
+246.53%
-38.5M
+83.33%
-21.0M
+25,304.82%
-82,735
+261.07%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-214,424
-59.17%
-525,121
-100.55%
95.2M
+25.20%
76.0M
+51.06%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-66.02%
+92.66%
-34.27%
+39.99%
-24.48%
-23.43%
-31.97%
-8.60%
Return on Equity
-77.31%
+109.62%
-36.88%
+40.72%
-26.21%
-24.28%
-34.61%
-10.09%
Revenue Growth
133.94%
+321.18%
31.80%
-37.32%
50.74%
+320.10%
-23.05%
-132.79%
Current Ratio
5.69
-51.28%
11.69
-35.96%
18.25
+32.12%
13.81
-2.44%
Cash Ratio
4.50
-14.89%
5.28
-65.76%
15.43
+22.16%
12.63
+1.27%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow